Close filter

Yi Chung Law

联系信息

+65 6422 0888

Based in Singapore, Yi Chung Law is an active member of Egon Zehnder’s Health, Technology and Public & Social Sector practice groups, helping clients with their talent and leadership transformation goals. This includes long term CEO and C-Suite succession planning, Team Effectiveness and Board searches. He also leads the HR Practice for Singapore office.

I love that at our Firm, as we strive to change businesses and the world, we don’t lose sight of what matters – individuals and what makes each of us human.

Prior to joining Egon Zehnder, Yi Chung served as Director at the Singapore Ministry of Health Office of Healthcare Transformation (MOHT), where he was involved in launching the first nationwide public telehealth service and developing the roadmap for the wider transformation of Singapore’s primary care sector. He spent the first decade of his public service career at the Singapore Economic Development Board (EDB), where he worked closely with global companies across various sectors to chart their growth in Asia. He also led the development of Singapore’s national life sciences R&D investment strategies and founded EDB’s Switzerland office.

Yi Chung has an M.Phil in Bioscience Enterprise from the University of Cambridge and a B.Sc (Hons) in Biomedical Engineering with a second major in French.

我的专长领域

联系我们
Send Yi Chung a Message
浏览全部
智识与洞见

全球相关顾问

郏晓宇

郏晓宇

上海, 北京

郏晓宇是亿康先达合伙人,负责领导亿康先达大中华区消费品行业咨询业务。他在高管寻访和领导力评估与发展领 阅读更多

Claire Thomas

Claire Thomas

London

Claire Thomas is a senior advisor with Egon Zehnder. She brings contemporary corporate PLC experience with 29 years’ proven success as a senior leader… 阅读更多

Barbara Kroll

Barbara Kroll

London

Barbara Kroll, based in London, supports clients across Europe as a member of Egon Zehnder’s Technology and Communications Practice. 阅读更多

Changing language
Close icon

You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.

Continue to the website

Back to top